M&A Deal Summary

COC Farmaceutici Acquires Tubilux Pharma

On October 1, 2020, COC Farmaceutici acquired life science company Tubilux Pharma

Acquisition Highlights
  • This is COC Farmaceutici’s 1st transaction in the Life Science sector.
  • This is COC Farmaceutici’s 1st transaction in Italy.

M&A Deal Summary

Date 2020-10-01
Target Tubilux Pharma
Sector Life Science
Buyer(s) COC Farmaceutici
Deal Type Add-on Acquisition

Target

Tubilux Pharma

S. Agata Bolognese, Italy
Tubilux Pharma is a contract developer and manufacturer of eye care pharmaceuticals (liquids, gels, or suspensions). Tubilux Pharma offers all its customers a wide range of top quality products, services, and full-service support activities.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

COC Farmaceutici

S. Agata Bolognese, Italy

Category Company
Founded 1985
Sector Life Science
DESCRIPTION

COC Farmaceutici produces pharmaceutical products for ophthalmic use and inhalation, plus cosmetic products. COC Farmaceutici Srl specializes in contract manufacturing, filling, and packaging of medicines, medical and diagnostic devices, cosmetics, and veterinary products, in liquid, cream, or gel form. COC Farmaceutici was founded in 1985 and is based in S. Agata Bolognese, Italy.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2020 M&A 1 of 1